Literature DB >> 33531909

Effect of Stem Cell-Derived Extracellular Vesicles on Damaged Human Corneal Endothelial Cells.

Raffaele Nuzzi1, Lola Buono2, Simona Scalabrin1, Marco De Iuliis1, Benedetta Bussolati2.   

Abstract

PURPOSE: Human corneal endothelial cells (HCECs) are essential to visual function; however, since they have limited proliferative capacity in vivo, they are prone to corneal endothelial dysfunction. At present, the only treatment is a corneal transplantation from donor cadavers. Also, due to a global shortage of donor corneas, it is important to find alternative strategies. Recent studies highlight that stem cell-derived extracellular vesicles (EVs) play a relevant role in stem cell-induced regeneration by reprogramming injured cells and inducing proregenerative pathways. The aim of this work is to evaluate whether EVs derived from mesenchymal stem cells (MSC-EVs) are able to promote regeneration of damaged HCECs.
METHODS: We isolated HCECs from discarded corneas in patients undergoing corneal transplantation or enucleation (N = 23 patients). Bone marrow mesenchymal stem cells (MSCs) were obtained from Lonza, cultured, and characterized. MSC-EVs were obtained from supernatants of MSCs. In order to establish a valid in vitro damage model to test the regenerative potential of EVs on HCECs, we evaluated the proliferation rate and the apoptosis after exposing the cells to serum-deprived medium at different concentrations for 24 hours. We then evaluated the HCEC migration through a wound healing assay.
RESULTS: In the selected serum deprivation damage conditions, the treatment with different doses of MSC-EVs resulted in a significantly higher proliferation rate of HCECs at all the tested concentrations of EVs (5-20 × 103 MSC-EV/cell). MSC-EVs/cell induced a significant decrease in number of total apoptotic cells after 24 hours of serum deprivation. Finally, the wound healing assay showed a significantly faster repair of the wound after HCEC treatment with MSC-EVs.
CONCLUSIONS: Results highlight the already well-known proregenerative potential of MSC-EVs in a totally new biological model, the endothelium of the cornea. MSC-EVs, indeed, induced proliferation and survival of HCECs, promoting the migration of HCECs in vitro.
Copyright © 2021 Raffaele Nuzzi et al.

Entities:  

Year:  2021        PMID: 33531909      PMCID: PMC7834816          DOI: 10.1155/2021/6644463

Source DB:  PubMed          Journal:  Stem Cells Int            Impact factor:   5.443


  92 in total

1.  The developing corneal endothelium: correlation of morphology, hydration and Na/K ATPase pump site density.

Authors:  M M Stiemke; H F Edelhauser; D H Geroski
Journal:  Curr Eye Res       Date:  1991-02       Impact factor: 2.424

2.  Expression of cell cycle-associated proteins in human and rabbit corneal endothelium in situ.

Authors:  N C Joyce; S E Navon; S Roy; J D Zieske
Journal:  Invest Ophthalmol Vis Sci       Date:  1996-07       Impact factor: 4.799

3.  Intracorneal epithelial ingrowth after descemet stripping endothelial keratoplasty and stromal puncture.

Authors:  Reema Bansal; Aparna Ramasubramanian; Pranab Das; Jaspreet Sukhija; Arun K Jain
Journal:  Cornea       Date:  2009-04       Impact factor: 2.651

4.  MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles.

Authors:  Hongqi Xin; Yi Li; Zhongwu Liu; Xinli Wang; Xia Shang; Yisheng Cui; Zheng Gang Zhang; Michael Chopp
Journal:  Stem Cells       Date:  2013-12       Impact factor: 6.277

5.  Induced pluripotent stem cells restore function in a human cell loss model of open-angle glaucoma.

Authors:  Diala W Abu-Hassan; Xinbo Li; Eileen I Ryan; Ted S Acott; Mary J Kelley
Journal:  Stem Cells       Date:  2015-03       Impact factor: 6.277

6.  Immunomodulatory Potential of Human Adipose Mesenchymal Stem Cells Derived Exosomes on in vitro Stimulated T Cells.

Authors:  Rebeca Blazquez; Francisco Miguel Sanchez-Margallo; Olga de la Rosa; Wilfried Dalemans; Verónica Alvarez; Raquel Tarazona; Javier G Casado
Journal:  Front Immunol       Date:  2014-11-04       Impact factor: 7.561

7.  Promoting the expansion and function of human corneal endothelial cells with an orbital adipose-derived stem cell-conditioned medium.

Authors:  Peng Sun; Lin Shen; Canwei Zhang; Liqun Du; Xinyi Wu
Journal:  Stem Cell Res Ther       Date:  2017-12-20       Impact factor: 6.832

8.  Renal Regenerative Potential of Different Extracellular Vesicle Populations Derived from Bone Marrow Mesenchymal Stromal Cells.

Authors:  Stefania Bruno; Marta Tapparo; Federica Collino; Giulia Chiabotto; Maria Chiara Deregibus; Rafael Soares Lindoso; Francesco Neri; Sharad Kholia; Sara Giunti; Sicheng Wen; Peter Quesenberry; Giovanni Camussi
Journal:  Tissue Eng Part A       Date:  2017-06-13       Impact factor: 3.845

9.  Human liver stem cell-derived extracellular vesicles enhance cancer stem cell sensitivity to tyrosine kinase inhibitors through Akt/mTOR/PTEN combined modulation.

Authors:  Valentina Fonsato; Michela De Lena; Stefania Tritta; Alessia Brossa; Ruggero Calvetti; Ciro Tetta; Giovanni Camussi; Benedetta Bussolati
Journal:  Oncotarget       Date:  2018-11-16

10.  Current Biosafety Considerations in Stem Cell Therapy.

Authors:  Masoumeh Mousavinejad; Peter W Andrews; Elham Kargar Shoraki
Journal:  Cell J       Date:  2016-05-30       Impact factor: 2.479

View more
  7 in total

Review 1.  Mesenchymal Stem Cell-Derived Extracellular Vesicles as Non-Coding RNA Therapeutic Vehicles in Autoimmune Diseases.

Authors:  Olga Martinez-Arroyo; Ana Ortega; Maria J Forner; Raquel Cortes
Journal:  Pharmaceutics       Date:  2022-03-29       Impact factor: 6.525

2.  Extracellular Vesicles Derived From Human Corneal Endothelial Cells Inhibit Proliferation of Human Corneal Endothelial Cells.

Authors:  Mohit Parekh; Hefin Rhys; Tiago Ramos; Stefano Ferrari; Sajjad Ahmad
Journal:  Front Med (Lausanne)       Date:  2022-02-04

3.  A Combined Procedure of Intrastromal Corneal Rings Explantation and Penetrating Keratoplasty in a Patient With Keratoconus: A Case Report.

Authors:  Raffaele Nuzzi; Flavia Tripoli; Alessandro Rossi; Andrea Ghilardi
Journal:  Front Med (Lausanne)       Date:  2022-03-11

4.  Intravitreal Administration Effect of Adipose-Derived Mesenchymal Stromal Cells Combined with Anti-VEGF Nanocarriers, in a Pharmaceutically Induced Animal Model of Retinal Vein Occlusion.

Authors:  Eleni Gounari; Anastasia Komnenou; Evangelia Kofidou; Stavroula Nanaki; Dimitrios Bikiaris; Stavroula Almpanidou; Kokkona Kouzi; Vasileios Karampatakis; George Koliakos
Journal:  Stem Cells Int       Date:  2022-02-23       Impact factor: 5.443

5.  Therapeutic Potential of Mesenchymal Stem Cells versus Omega n - 3 Polyunsaturated Fatty Acids on Gentamicin-Induced Cardiac Degeneration.

Authors:  Fatma Y Meligy; Hanan Sharaf El-Deen Mohammed; Tarek M Mostafa; Mohamed M Elfiky; Israa El-Sayed Mohamed Ashry; Ahmed M Abd-Eldayem; Nermin I Rizk; Dina Sabry; Eman S H Abd Allah; Salwa Fares Ahmed
Journal:  Pharmaceutics       Date:  2022-06-22       Impact factor: 6.525

6.  Mesenchymal Stem Cell-Derived Extracellular Vesicles Protect Human Corneal Endothelial Cells from Endoplasmic Reticulum Stress-Mediated Apoptosis.

Authors:  Lola Buono; Simona Scalabrin; Marco De Iuliis; Adele Tanzi; Cristina Grange; Marta Tapparo; Raffaele Nuzzi; Benedetta Bussolati
Journal:  Int J Mol Sci       Date:  2021-05-06       Impact factor: 5.923

7.  Corneal endothelial regeneration in human eyes using endothelium-free grafts.

Authors:  Lu-Yi Ying; Wen-Ya Qiu; Bing-Hong Wang; Ping Zhou; Bei Zhang; Yu-Feng Yao
Journal:  BMC Ophthalmol       Date:  2022-01-21       Impact factor: 2.209

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.